Peptide Research Index
⚠️ Educational only · Not medical advice · Consult a doctor · Most peptides are research-only / not FDA-approved for human use
"The Immune Fortress"
Enhanced immunity, faster illness recovery, gut-immune axis support
Thymosin Alpha-1 supercharges immune cell function (T-cells, NK cells, dendritic cells), while BPC-157 heals the gut lining where 70% of the immune system resides. Attacking immune weakness from both sides.
Tα1 enhances T-cell maturation, NK cell activity, and dendritic cell function for improved pathogen response. BPC-157 repairs gut mucosal integrity, supporting the gut-associated lymphoid tissue (GALT) — the body's largest immune organ.
Typical Ratio: Thymosin Alpha-1 1.6mg + BPC-157 500mcg
Tα1 1.6mg SubQ 2x/week + BPC-157 250-500mcg SubQ daily. Cycle 8-24 weeks. Ideal during cold/flu season or post-illness.
Week 1
Immune activation; NK cell and T-cell enhancement begins
Weeks 2–4
Improved immune response; gut healing supports immune function
Months 2–3
Sustained immune modulation; reduced frequency of illness
Long-term
Long-term immune resilience; gut-immune axis restoration
Thymosin Alpha-1 approved in 35+ countries. Both peptides well-tolerated. Excellent safety profiles.